Page 50 - DIAGEN-EN
P. 50

Solid Tumor  primeFISH Products


                SOLIDTUMOR
                PANEL



                17-220 NTRK3 (15q25) BREAKAPART



                NTRK3 is a receptor tyrosine kinase (TK) for neurotro-  thyroid cancer, secretory breast carcinoma, and mammary
                phin 3 (NT3) and plays an important role in celi survival   analogue secretory carcinoma of the salivary gland. The
                and development of the central and peripheral nervous   most common rearrangement involving the NTRK3 gene
                systems. Transloca  tions affecting the NTRK3 gene have   is t(12;15) (pl3;q25); Asa result, fusion occurs between the
                been reported in many cancer types, including glioblas    5’ part of the ETV6 gene and the 3’ part of the NTRK3 gene.
                tomas, Philadelphia chromosome-like acute lymphoblastic   This fusion gene encodes a hybrid protein consisting of
                leukemia, congenital fibrosarco  mas, cellular mesoblastic   the TK portion of NTRK3 and the dimerization portion of
                nephromas, acute myeloid leukemia, radiation-associated   ETV6, resulting in a ligand-independent TK activity.













                                                                                                  BREAKAPART











                              D15S1119  D15S99     SHGC-102137  D15S168E
                                              3'  5'
                                                                                  NORMAL
                           Cent                                    Tel
                                             NTRK3

                                  518 kb                 771 kb



                                                                               RE-ARRANGEMENT

                       15q25.3-q26.1







                                  (Not to scale)



       www.diagen.com.tr  References
                Amatu A, et al. (2016) ESMO Open 1: e000023.
                Nagasubramanian R, et al. (2016) Pediatr Blood Cancer 63: 1468-70.
                Wang L, et al. (2017) J Mol Diagn 19: 387-96.





        50     PRODUCT CATALOGUE
   45   46   47   48   49   50   51   52   53   54   55